World's largest maker of disposable nitrile and latex examination gloves, also producing picture-frame mouldings.
World's largest maker of disposable nitrile and latex examination gloves, also producing picture-frame mouldings.
Sells gloves in volume to distributors and brand owners, so price follows glove capacity and demand, which spiked and then collapsed around the pandemic. Most output is exported, with the US a big market, so US tariffs matter. Its second product, plastic picture-frame moulding, is an older business separate from healthcare.
In one line: A Chinese Kimberly-Clark/Top Glove for exam gloves.
Moat: narrow (scale, cost advantage). Very large manufacturing scale gives a cost edge in a commodity glove market.
Headquarters: Yantai, Shandong, China · Employees: 12,941
Size Intco Medical Technology (300677.SZ) is a China Health Care company (Medical Specialties) with a market value of $4.82B, the 486th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥49.46 on 18 Nov 2026.
Performance Over six months the shares fell 1.8%, against +23.4% for the median peer and -20.0% for the China market (cap-weighted) — 5th lowest of 21 in its peer set.
Growth Revenue grew 33.2% over the last twelve months (peer median +5.6%); the operating margin is 19.5% (peer median 13.6%).
Valuation It trades at 18.5× forward earnings against a peer median of 20.4× (7th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about -4% a year for seven years (Req g). Recent delivered growth is -6%, so the hurdle is +3 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 3.7 points above its cost of capital (5.0% WACC).
Next results Next results expected around 28 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥13.1B | CN¥9.88B | CN¥9.51B | CN¥6.85B | CN¥6.56B |
| Revenue growth | — | +4% | +39% | +4% | — |
| Gross profit | CN¥4.92B | CN¥2.10B | CN¥2.01B | CN¥707M | CN¥672M |
| EBITDA | n/a | CN¥1.84B | CN¥1.75B | CN¥553M | CN¥556M |
| Net income | CN¥298M | CN¥1.01B | CN¥1.47B | CN¥383M | CN¥629M |
| Free cash flow | CN¥2.40B | -CN¥282M | -CN¥432M | -CN¥852M | -CN¥574M |
| Capital expenditure | CN¥1.51B | CN¥2.57B | CN¥1.79B | CN¥1.44B | CN¥1.72B |
| Total debt | CN¥17.8B | CN¥17.6B | CN¥13.4B | CN¥7.37B | CN¥1.70B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Intco Medical Technology 300677.SZ | $4.82B | -2% | +33% | 20% | 18.5× | -3.5% |
| Blue Sail Medical 002382.SZ | $801M | -21% | +23% | 7% | 10.9× | -7.2% |
| Ansell ANN.AX | $4.31B | +73% | +2% | 15% | 18.9× | 10.5% |
| Riverstone AP4.SI | $880M | -22% | -4% | 25% | 16.4× | 3.8% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 300677.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +12.5% | +3.7% | 5th highest of 21 |
| 6-month return | -1.8% | +23.4% | 5th lowest of 21 |
| Distance from 52-week high | -27.7% | -16.4% | 7th lowest of 21 |
| Revenue growth (TTM) | +33.2% | +5.6% | 2nd highest of 21 |
| Operating margin | 19.5% | 13.6% | 4th highest of 20 |
| Forward P/E | 18.5× | 20.4× | 7th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | -3.5% | 10.9% | 3rd least demanding of 18 |
| Growth delivered (Del g) | -6.4% | +8.2% | 2nd lowest of 18 |
| Hurdle (Req g minus delivered) | +2.9 pp | +1.5 pp | 7th most demanding of 18 |
| ROIC minus cost of capital | +3.7 pp | +1.1 pp | 5th highest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Intco Medical Technology 300677.SZ | China | $4.82B | -2% | +33% | 20% | 18.5× | -3.5% | -6.4% |
| DiaSorin DIA.MI | Italy | $4.81B | +24% | -3% | 24% | 20.5× | 4.1% | +6.3% |
| MiniMed MMED | United States | $4.78B | +46% | +14% | 14% | 26.3× | n/a | n/a |
| Sotera Health SHC | United States | $4.65B | +5% | +7% | 37% | 15.7× | 14.4% | +7.3% |
| GRAIL GRAL | United States | $4.59B | +67% | +17% | -332% | n/a | n/a | n/a |
| Merit Medical Systems MMSI | United States | $5.15B | +33% | +9% | 14% | 19.1× | 12.6% | +9.5% |
| ICU Medical ICUI | United States | $4.46B | +38% | -6% | 8% | 19.4× | 18.9% | +11.9% |
| LivaNova LIVN | United States | $5.21B | +28% | +12% | 15% | 20.9× | 14.2% | +8.2% |
| Stevanato STVN | United States | $4.19B | -13% | +12% | 18% | 22.5× | 13.1% | +12.1% |
| Jiangsu Yuyue Medical Equipment & Supply 002223.SZ | China | $4.18B | -3% | -1% | 13% | 20.0× | 4.9% | +3.4% |
| Haemonetics HAE | United States | $5.59B | +106% | +4% | 19% | 20.7× | 10.9% | +8.9% |
| Fielmann FIE.DE | Germany | $3.92B | -3% | +3% | 14% | 17.1× | -5.5% | +11.3% |
| CareDx CDNA | United States | $3.91B | +252% | +39% | 1% | 50.6× | n/a | n/a |
| Andon Health 002432.SZ | China | $3.86B | -24% | -30% | -26% | 16.1× | -6.6% | -7.4% |
| APT Medical 688617.SS | China | $6.06B | +23% | +28% | 37% | 38.6× | 9.0% | +40.1% |
| Envista NVST | United States | $3.81B | 0% | +10% | 12% | 14.7× | 4.8% | +7.1% |
| SCHOTT Pharma AG & Co. KGaA 1SXP.DE | Germany | $3.73B | +32% | +4% | 15% | 23.0× | 12.7% | +11.0% |
| Shandong Weigao Blood Purification Products 603014.SS | China | $3.63B | -1% | +4% | n/a | 20.4× | -1.2% | +8.1% |
| Tecan TECN.SW | Switzerland | $3.60B | +59% | -4% | 1% | 35.5× | 45.4% | +3.8% |
| Teleflex TFX | United States | $6.58B | +23% | -29% | 12% | 16.7× | 16.5% | -4.7% |
| Sumitomo Bakelite 4203.T | Japan | $3.50B | +7% | +15% | 13% | 15.9× | 8.6% | +8.9% |